GABLIN CR 165MG TAB

GABLIN CR 165MG TAB is a controlled-release gabapentin formulation engineered for sustained neuropathic pain management and seizure prophylaxis. The extended-release technology delivers 165mg gradually throughout the day, maintaining consistent therapeutic levels while reducing dosing frequency. This formulation addresses post-herpetic neuralgia, diabetic peripheral neuropathy, and partial seizure disorders with enhanced convenience and improved compliance. The controlled-release mechanism minimizes peak-trough fluctuations, optimizing symptom control and tolerability. Particularly beneficial for patients requiring stable drug exposure or those experiencing side effects with immediate-release formulations. The tablet format ensures straightforward administration with flexible scheduling. Regular clinical assessment is recommended to evaluate therapeutic efficacy and adjust dosing as needed. Consult your healthcare provider regarding appropriate dosage, potential interactions, and contraindications before commencing treatment.

GABLIN CR 165MG TAB